Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. January 23, 2015 - Mylan
Pharmaceuticals Inc. sued by UCB Pharma GmbH for patent infringement in
District of ...
Pfizer Inc. et al v. Mylan Inc. et al. June 16, 2010 - Mylan Inc. sued by Pfizer
Pharmaceuticals LLC for patent infringement in District of Delaware. 1:10-cv-
Pfizer Inc. et al v. Fresenius Kabi USA LLC. November 13, 2013 - Fresenius Kabi
USA LLC sued by Wyeth Holdings LLC for patent infringement in District of ...
Apr 24, 2016 ... Teva Pharmaceuticals USA Inc. et al. v. .... Plaintiffs: Pfizer Inc.; Wyeth LLC; Pfizer
Pharmaceuticals LLC; .... Mylan Pharmaceuticals Inc. et al.
Feb 6, 2014 ... PFIZER INC. v. ... ticals USA, Inc., et al. were JAMES GALBRAITH, ANTONY.
PFEFFER ... Ltd.; and Mylan Pharmaceuticals, Inc. (collectively,.
Oct 22, 2014 ... A Delaware federal judge ruled Wednesday that Pfizer Inc.'s patent for cancer
drug Sutent was nonobvious and could stand, despite a challenge from Mylan
Pharmaceuticals Inc. in Pfizer's suit seeking to ... The case is Pfizer Inc. et al. v.
Mylan Inc. et al., case number 1:10-cv-00528, in the U.S. District Court ...
Jun 25, 2012 ... ... et al., Pfizer Inc. et al. v. Lupin Ltd. et al., Pfizer Inc. et al. v. Mylan
Pharmaceuticals Inc. et al., Pfizer Inc. et al. v. Roxane Laboratories Inc. et al.
Prinston Pharmaceutical Inc., et. al., 15-CV-00902 (SLR)(D.Del). ... Senju
Pharmaceutical Co., Ltd., et al. v. .... Represented Mylan in ANDA litigation
involving Pfizer's cardiovascular product CADUET®, the active ingredients of
which are ...
Acorda Therapeutics Inc. v. ... Apotex v. Pfizer Inc. and Greenstone LLC (S.D. Fla.
) Represented Children's Hospital and Novartis in Hatch-Waxman ... Mylan
Pharmaceuticals (D.N.J.), Aventis v. ... Zenith Goldline Pharmaceuticals, Inc., et al
pharmaceutical firms to provide economic and financial analyses and expert
opinions relating to Hatch-Waxman ... Inc., et. al. » Hoffman-LaRoche, Inc. v.
Cobalt. Pharmaceuticals, Inc. ... Pfizer, Inc., et. seq. v. Purepac ... Ltd. v. Mylan Inc.
, et. al.